Alternatives
Alternatives to PlushCare
PlushCare scores 61/100 on our Cost-Efficiency Index . Here are other programs to consider, each scored the same way. Partners are listed first.
PlushCare at a glance
- Semaglutide
- $499/moBrand Wegovy through NovoCare Pharmacy, plus a separate fee
- Tirzepatide
- $299/mo2.5 mg brand Zepbound vial through LillyDirect; $399 at 5 mg, $449 at 7.5 mg and up, plus a separate fee
- Coverage
- All 50 states
- Brand-name GLP-1s
- Yes
- Oral option
- No
- Pricing verified
- October 2026
6 of the 8 programs below list semaglutide for less than PlushCare's $499 a month. 4 of the 8 list tirzepatide for less than its $299 a month.
PlushCare (a Transcarent, Inc. subsidiary) is a virtual primary-care platform whose board-certified MDs can prescribe brand-name GLP-1s (via insurance or Novo Nordisk's NovoCare cash-pay program) or compounded semaglutide/tirzepatide in 40 states plus DC while the brand drugs are on FDA's shortage list.
Best for: Patients who want a real board-certified physician managing GLP-1s alongside general primary care, and are prepared to navigate insurance or a manufacturer cash-pay program rather than a single flat price.
What PlushCare does well
- Board-certified physicians (not NP-only) available in all 50 states for general virtual primary care
- Lists the Zepbound self-pay prices by dose on its own page: vials at $299, $399 and $449 a month, pens at $650
- Owned by Transcarent, a venture-backed platform with a named, traceable corporate lineage
- Insurer prior-authorization outreach and an in-app prescription discount card for patients who do have coverage
Why readers look for an alternative
- Compounded semaglutide ($149 at 0.25 mg, $299 above) is offered only while the brand drug is on FDA's shortage list, and compounded options only in 40 states plus DC
- A $19.99/mo membership (first month free) and, without insurance, a $129 visit come on top of the medication price
- The Wegovy page still quotes a $199 first-months price 'valid through March 2026', a date that has passed; its own headline says from $499
- Facing a class-action settlement (Robbins v. PlushCare) alleging patients were enrolled in a recurring monthly subscription without clear disclosure or an easy cancellation path
- GLP-1 prescribing is a clinician's in-visit judgment call, not guaranteed at signup
- Partner01A94/ 100Index
CoreAge Rx
CoreAge Rx charges one flat price at every dose, $99 a month for semaglutide and $149 for tirzepatide, with no membership fee.
- Sema
- $99/mo
- Tirz
- $149/mo
- Coverage
- All 50 states
- Brand
- Compounded
Compared with PlushCare: $400/mo less for semaglutide · $150/mo less for tirzepatide · compounded only, no brand-name GLP-1s
- 02C59/ 100Index
RNK Health
PartnerCompounded semaglutide from $197 a month and tirzepatide from $297, with the doctor visit, medication, supplies and shipping in one monthly price you can cancel.
- Sema
- From $197/moCompounded, month to month
- Tirz
- From $297/moCompounded, month to month
- Coverage
- Multi-state
- Brand
- Compounded
Compared with PlushCare: $302/mo less for semaglutide · $2/mo less for tirzepatide · compounded only, no brand-name GLP-1s
- 03C62/ 100Index
Florida Weight Loss MD
Florida Surgery & Weight Loss Center offers physician-led GLP-1 care across Florida, with published compounded program prices and separate brand-name prescription evaluations.
- Sema
- $179/moStarting compounded program, plus $79 initial evaluation
- Tirz
- $279/moStarting compounded program, plus $79 initial evaluation
- Coverage
- Florida
- Brand
- Yes
Compared with PlushCare: $320/mo less for semaglutide · $20/mo less for tirzepatide · offers an oral option
- 04C62/ 100Index
Maven Clinic
Maven Clinic's self-pay GLP-1 care prescribes only brand-name drugs, from a $149/mo Wegovy or Foundayo pill to $299/mo Zepbound, plus a membership of $39 the first month and $150 a month after.
- Sema
- $149/moBrand Wegovy pill, membership required
- Tirz
- $299/moBrand Zepbound, membership required
- Coverage
- Multi-state
- Brand
- Yes
Compared with PlushCare: $350/mo less for semaglutide · offers an oral option
- 05C62/ 100Index
Rila
Rila offers compounded semaglutide and tirzepatide as injections or dissolving tablets, with clinical care through DrTelX and named dispensing pharmacies.
- Sema
- Shared injectable floor $198/mo with six-month commitment; semaglutide-specific total not disclosed
- Tirz
- Shared injectable floor $198/mo with six-month commitment; tirzepatide-specific total not disclosed
- Coverage
- Multi-state
- Brand
- Compounded
Compared with PlushCare: compounded only, no brand-name GLP-1s · offers an oral option
- 06C62/ 100Index
Nex Gen Health Rx
Nex Gen Health Rx sells compounded semaglutide at $190 and tirzepatide at $239 per 30-day supply, names the pharmacy that fills them, and advertises $99 and $149 on its homepage without saying those are twelve-month prepay rates.
- Sema
- $190Per 30-day supply month-to-month (the homepage's $99 is the 360-day prepay rate)
- Tirz
- $239Per 30-day supply month-to-month (the homepage's $149 is the 360-day prepay rate)
- Coverage
- Multi-state
- Brand
- Compounded
Compared with PlushCare: $309/mo less for semaglutide · $60/mo less for tirzepatide · compounded only, no brand-name GLP-1s
- 07C62/ 100Index
Solaya MD
Solaya MD offers compounded GLP-1 care with a named pharmacy and clinical network; drug-specific pricing is available after assessment.
- Sema
- Not disclosedRequest a drug-specific price before enrolling
- Tirz
- Not disclosedRequest a drug-specific price before enrolling
- Coverage
- All 50 states
- Brand
- Compounded
Compared with PlushCare: compounded only, no brand-name GLP-1s · offers an oral option
- 08C62/ 100Index
MEDVi
MEDVi charges $179 for the first month of compounded semaglutide and $299 for every refill after, with the visit and medication in one price; brand Wegovy and Zepbound carry a $99 membership plus the drug's cost.
- Sema
- $299/moMonth-to-month refill price; first month $179, compounded
- Tirz
- Not disclosed
- Coverage
- Not published
- Brand
- Yes
Compared with PlushCare: $200/mo less for semaglutide · offers an oral option
Regulatory note: the FDA issued a warning letter to MEDVi, LLC dba MEDVi in February 2026. We still list and link to MEDVi; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — it never changes the Cost-Efficiency Index. Pricing and coverage reflect public disclosures at last review; confirm on each provider's site. Not medical advice. See our disclosure.